https://www.selleckchem.com/pr....oducts/Gefitinib.htm
The amount of collagen in the lung of the RS-504393-treated mice was lower compared with that in the PBS-treated mice. These data suggest that CCR2 antagonist RS-504393 may be a therapeutic agent for human scleroderma. © 2020 John Wiley Sons A/S. Published by John Wiley Sons Ltd.BACKGROUND Patellofemoral pain (PFP) patients show increased prevalence of patellar malalignment. Structural and alignment abnormalities of the patellofemoral joint (PFJ) may play a role in development of PFP and patellofemoral osteoarthritis (PFOA
Like
Comment
Share
